| Not Yet Recruiting | Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities NCT07530640 | Children's Hospital of Fudan University | — |
| Not Yet Recruiting | Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learni NCT07405658 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Not Yet Recruiting | MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS) NCT07491926 | Meyer Children's Hospital IRCCS | — |
| Recruiting | Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease NCT05643651 | Children's Hospital of Fudan University | Phase 4 |
| Not Yet Recruiting | Non Inferiority KawasakI Trial With Anakinra NCT06697431 | Meyer Children's Hospital IRCCS | Phase 4 |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Recruiting | Kawasaki MATCH Trial NCT07291245 | University of California, San Diego | N/A |
| Enrolling By Invitation | Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease NCT06641843 | West China Second University Hospital | — |
| Recruiting | Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasak NCT06978439 | Children's Hospital of Fudan University | Phase 4 |
| Recruiting | A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in NCT04656184 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Unknown | Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases NCT05911386 | Central Hospital, Nancy, France | — |
| Enrolling By Invitation | The Value of Cardiovascular Imaging in Kawasaki Disease NCT06641817 | West China Second University Hospital | — |
| Unknown | A Blood Test to Diagnose Kawasaki Disease NCT05091229 | HBI Solutions Inc. | — |
| Recruiting | Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years NCT06993636 | Children's Hospital of Fudan University | — |
| Unknown | Clinical Precise Diagnosis and Treatment in the Kawasaki Disease NCT05347901 | Affiliated Hospital of Nantong University | — |
| Recruiting | European and North Indian Cohort of KaWasaki dIsease NCT06305611 | Meyer Children's Hospital IRCCS | — |
| Recruiting | Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) NCT06775457 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Unknown | Defibrotide in Children With High Risk Kawasaki Disease NCT04777422 | New York Medical College | Phase 2 |
| Withdrawn | Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Dise NCT04535518 | Children's Hospital of Fudan University | Phase 3 |
| Completed | Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Dis NCT04538495 | University of California, San Diego | — |
| Completed | Kawasaki Disease During the COVID-19 Epidemic NCT06309303 | IRCCS Burlo Garofolo | — |
| Recruiting | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Stan NCT04278404 | Duke University | — |
| Completed | Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Dise NCT04078568 | Children's Hospital of Fudan University | Phase 3 |
| Completed | Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities NCT03915795 | Children's Hospital of Fudan University | — |
| Completed | Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki NCT04747847 | University of California, San Diego | EARLY_Phase 1 |
| Completed | Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease NCT04003844 | Green Cross Corporation | Phase 4 |
| Completed | Cardiovascular Status of Children 5 Years After Kawasaki Disease NCT03750123 | Medical University of Warsaw | — |
| Withdrawn | Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease NCT02980263 | Novartis Pharmaceuticals | Phase 2 |
| Unknown | A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki D NCT02951234 | Chang Gung Memorial Hospital | N/A |
| Completed | Acute Abdomen in Kawasaki Disease NCT03902262 | National Institute of Pediatrics, Mexico | — |
| Completed | Anakinra and Kawasaki Disease NCT02390596 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Unknown | Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young NCT02771288 | National Taiwan University Hospital | N/A |
| Completed | Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease NCT02179853 | University of California, San Diego | Phase 1 / Phase 2 |
| Completed | Different Doses of IVIG for Kawasaki Disease NCT02439996 | Children's Hospital of Fudan University | Phase 3 |
| Unknown | A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalitie NCT03200561 | National Taiwan University Hospital | Phase 3 |
| Active Not Recruiting | Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease NCT01917721 | Hawaii Pacific Health | Phase 2 |
| Unknown | Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease NCT02359643 | Chang Gung Memorial Hospital | N/A |
| Completed | Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 NCT02317913 | Children's Hospital of Fudan University | — |
| Unknown | Genetic Determinants of Kawasaki Disease NCT03861130 | Imperial College London | — |
| Completed | Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial NCT02298062 | Fudan University | Phase 3 |
| Completed | Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnor NCT01431105 | University of California, San Diego | Phase 1 / Phase 2 |
| Completed | Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease NCT01524939 | Green Cross Corporation | Phase 4 |
| Completed | Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease NCT01440075 | Hospices Civils de Lyon | N/A |
| Unknown | Measurement of Antibodies in Adults With a History of Kawasaki Disease NCT02853266 | Hospices Civils de Lyon | — |
| Completed | Reproductive Health in Men and Women With Vasculitis NCT02176070 | University of South Florida | — |
| Recruiting | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168 | Sanford Health | — |
| Completed | Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging NCT00861848 | University of Nebraska | — |
| Completed | Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease NCT00760435 | University of California, San Diego | Phase 3 |
| Completed | A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease NCT00841789 | Michael Portman | Phase 2 |
| Unknown | Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease NCT02114099 | National Taiwan University Hospital | Phase 2 |
| Withdrawn | Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease NCT00305201 | Pontificia Universidad Catolica de Chile | Phase 2 |
| Completed | A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease NCT00162032 | Lantheus Medical Imaging | Phase 3 |
| Completed | A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects NCT00162045 | Lantheus Medical Imaging | Phase 1 / Phase 2 |
| Completed | Infliximab (Remicade) for Patients With Acute Kawasaki Disease NCT00271570 | University of California, San Diego | Phase 1 |
| Unknown | Etiology Study of Kawasaki Disease NCT00154596 | National Taiwan University Hospital | — |